mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.08 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |